Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 1490 entries
Sorted by: Best Match Show Resources per page
Association between learning environment interventions and medical student well-being: a systematic review

education interventions

Meli L, Falzon L.
GSID: nOMUTl1fm5QJ
LT Wasson, A Cusmano, L Meli, I Louh, L Falzon… - Jama, 2016 - jamanetwork.com

… The MERSQI was preferred to the Newcastle-Ottawa Scale–Education (NOS-E), another assessment tool for medical education research quality, because it was found to have generally higher interrater reliability (0.68-0.89) 11 than the NOS-E. This may be due to its...

Cite
Wasson, L. T., Cusmano, A., Meli, L., Louh, I., Falzon, L., Hampsey, M., ... & Davidson, K. W. (2016). Association between learning environment interventions and medical student well-being: a systematic review. Jama, 316(21), 2237-2252.
Wasson, Lauren T., et al. "Association between learning environment interventions and medical student well-being: a systematic review." Jama 316.21 (2016): 2237-2252.
Copy Download .nbib Format: MLA
[Cardiopathy in Down's syndrome].

Pathologica

Grillo R, Meli F, Sperandeo V, Accomando A.
PMID: 162001
Pathologica. 1979 May-Jun;71(1013):416-7.

No abstract available.

Cite
Grillo R, Meli F, Sperandeo V, et al. La cardiopatia nella sindrome di Down. [Cardiopathy in Down's syndrome]. Pathologica. 1979;71(1013):416-7
Grillo, R., Meli, F., Sperandeo, V., & Accomando, A. (1979). La cardiopatia nella sindrome di Down. [Cardiopathy in Down's syndrome]. Pathologica, 71(1013), 416-7.
Grillo, R, et al. "La cardiopatia nella sindrome di Down." [Cardiopathy in Down's syndrome]. Pathologica vol. 71,1013 (1979): 416-7.
Grillo R, Meli F, Sperandeo V, Accomando A. La cardiopatia nella sindrome di Down. [Cardiopathy in Down's syndrome]. Pathologica. 1979 May-Jun;71(1013):416-7. Italian. PMID: 162001.
Copy Download .nbib Format: NLM
A comparison of targetting of neuroblastoma with mIBG and anti L1-CAM antibody mAb chCE7: therapeutic efficacy in a neuroblastoma xenograft model and imaging of neuroblastoma patients.

European journal of nuclear medicine

Hoefnagel CA, Rutgers M, Buitenhuis CK, Smets LA, Kraker Jd, Meli M, Carrel F, Amstutz H, Schubiger PA, Novak-Hofer I.
PMID: 24623005
Eur J Nucl Med. 2001 Mar;28(3):359-68. doi: 10.1007/s002590000454.

Iodine-131 labelled anti L1-CAM antibody mAb chCE7 was compared with the effective neuroblastoma-seeking agent (131)I-labelled metaiodobenzylguanidine (MIBG) with regard to (a) its therapeutic efficacy in treating nude mice with neuroblastoma xenografts and (b) its tumour targetting ability in neuroblastoma...

Cite
Hoefnagel CA, Rutgers M, Buitenhuis CK, et al. A comparison of targetting of neuroblastoma with mIBG and anti L1-CAM antibody mAb chCE7: therapeutic efficacy in a neuroblastoma xenograft model and imaging of neuroblastoma patients. Eur J Nucl Med. 2001;28(3):359-68doi: 10.1007/s002590000454.
Hoefnagel, C. A., Rutgers, M., Buitenhuis, C. K., Smets, L. A., Kraker, J. d., Meli, M., Carrel, F., Amstutz, H., Schubiger, P. A., & Novak-Hofer, I. (2001). A comparison of targetting of neuroblastoma with mIBG and anti L1-CAM antibody mAb chCE7: therapeutic efficacy in a neuroblastoma xenograft model and imaging of neuroblastoma patients. European journal of nuclear medicine, 28(3), 359-68. https://doi.org/10.1007/s002590000454
Hoefnagel, C A, et al. "A comparison of targetting of neuroblastoma with mIBG and anti L1-CAM antibody mAb chCE7: therapeutic efficacy in a neuroblastoma xenograft model and imaging of neuroblastoma patients." European journal of nuclear medicine vol. 28,3 (2001): 359-68. doi: https://doi.org/10.1007/s002590000454
Hoefnagel CA, Rutgers M, Buitenhuis CK, Smets LA, Kraker Jd, Meli M, Carrel F, Amstutz H, Schubiger PA, Novak-Hofer I. A comparison of targetting of neuroblastoma with mIBG and anti L1-CAM antibody mAb chCE7: therapeutic efficacy in a neuroblastoma xenograft model and imaging of neuroblastoma patients. Eur J Nucl Med. 2001 Mar;28(3):359-68. doi: 10.1007/s002590000454. PMID: 24623005.
Copy Download .nbib Format: NLM
Analyzing historical trends in breast cancer biomarker expression: a feasibility study (1947-2009).

NPJ breast cancer

Krieger N, Habel LA, Waterman PD, Shabani M, Ellison-Loschmann L, Achacoso NS, Acton L, Schnitt SJ.
PMID: 26807440
NPJ Breast Cancer. 2015;1. doi: 10.1038/npjbcancer.2015.16. Epub 2015 Oct 07.

BACKGROUND/OBJECTIVES: Determining long-term trends in tumor biomarker expression is essential for understanding aspects of tumor biology amenable to change. Limiting the availability of such data, currently used assays for biomarkers are relatively new. For example, assays for the estrogen...

Cite
Krieger N, Habel LA, Waterman PD, et al. Analyzing historical trends in breast cancer biomarker expression: a feasibility study (1947-2009). NPJ Breast Cancer. 2015;1doi: 10.1038/npjbcancer.2015.16.
Krieger, N., Habel, L. A., Waterman, P. D., Shabani, M., Ellison-Loschmann, L., Achacoso, N. S., Acton, L., & Schnitt, S. J. (2015). Analyzing historical trends in breast cancer biomarker expression: a feasibility study (1947-2009). NPJ breast cancer, 1. https://doi.org/10.1038/npjbcancer.2015.16
Krieger, Nancy, et al. "Analyzing historical trends in breast cancer biomarker expression: a feasibility study (1947-2009)." NPJ breast cancer vol. 1 (2015). doi: https://doi.org/10.1038/npjbcancer.2015.16
Krieger N, Habel LA, Waterman PD, Shabani M, Ellison-Loschmann L, Achacoso NS, Acton L, Schnitt SJ. Analyzing historical trends in breast cancer biomarker expression: a feasibility study (1947-2009). NPJ Breast Cancer. 2015;1. doi: 10.1038/npjbcancer.2015.16. Epub 2015 Oct 07. PMID: 26807440; PMCID: PMC4721558.
Copy Download .nbib Format: NLM
Hairy cell leukemia followed by polycythemia vera: report of the first case.

Oxford medical case reports

Ipek YH, Fehmi H, Meliha N.
PMID: 26941958
Oxf Med Case Reports. 2016 Mar 02;2016(3):28-30. doi: 10.1093/omcr/omw005. eCollection 2016 Mar.

No abstract available.

Cite
Ipek YH, Fehmi H, Meliha N. Hairy cell leukemia followed by polycythemia vera: report of the first case. Oxf Med Case Reports. 2016;2016(3):28-30doi: 10.1093/omcr/omw005.
Ipek, Y. H., Fehmi, H., & Meliha, N. (2016). Hairy cell leukemia followed by polycythemia vera: report of the first case. Oxford medical case reports, 2016(3), 28-30. https://doi.org/10.1093/omcr/omw005
Ipek, Yonal-Hindilerden, et al. "Hairy cell leukemia followed by polycythemia vera: report of the first case." Oxford medical case reports vol. 2016,3 (2016): 28-30. doi: https://doi.org/10.1093/omcr/omw005
Ipek YH, Fehmi H, Meliha N. Hairy cell leukemia followed by polycythemia vera: report of the first case. Oxf Med Case Reports. 2016 Mar 02;2016(3):28-30. doi: 10.1093/omcr/omw005. eCollection 2016 Mar. PMID: 26941958; PMCID: PMC4773848.
Copy Download .nbib Format: NLM
US and CT of the Liver after Electric Shock.

Case reports in radiology

Sofić A, Bešlić N, Efendić A, Čarovac A, Šabanović J, Jahić E, Bukvić M, Krakonja F, Kupusović J.
PMID: 27006849
Case Rep Radiol. 2016;2016:9846357. doi: 10.1155/2016/9846357. Epub 2016 Feb 23.

Liver injuries caused by high voltage electricity are rare and result in high mortality and morbidity. They are produced by the resistance to the passage of electrical current through the tissue, which creates heat that leads to coagulation necrosis...

Cite
Sofić A, Bešlić N, Efendić A, et al. US and CT of the Liver after Electric Shock. Case Rep Radiol. 2016;2016:9846357doi: 10.1155/2016/9846357.
Sofić, A., Bešlić, N., Efendić, A., Čarovac, A., Šabanović, J., Jahić, E., Bukvić, M., Krakonja, F., & Kupusović, J. (2016). US and CT of the Liver after Electric Shock. Case reports in radiology, 20169846357. https://doi.org/10.1155/2016/9846357
Sofić, Amela, et al. "US and CT of the Liver after Electric Shock." Case reports in radiology vol. 2016 (2016): 9846357. doi: https://doi.org/10.1155/2016/9846357
Sofić A, Bešlić N, Efendić A, Čarovac A, Šabanović J, Jahić E, Bukvić M, Krakonja F, Kupusović J. US and CT of the Liver after Electric Shock. Case Rep Radiol. 2016;2016:9846357. doi: 10.1155/2016/9846357. Epub 2016 Feb 23. PMID: 27006849; PMCID: PMC4781946.
Copy Download .nbib Format: NLM
Controlling Disorder and Superconductivity in Titanium Oxynitride Nanoribbons with Anion Exchange.

ACS nano

Sluban M, Umek P, Jagličić Z, Buh J, Šmitek P, Mrzel A, Bittencourt C, Guttmann P, Delville MH, Mihailović D, Arčon D.
PMID: 26340376
ACS Nano. 2015 Oct 27;9(10):10133-41. doi: 10.1021/acsnano.5b03742. Epub 2015 Sep 14.

In recent years, conversion chemical reactions, which are driven by ion diffusion, emerged as an important concept for formation of nanoparticles. Here we demonstrate that the slow anion diffusion in anion exchange reactions can be efficiently used to tune...

Cite
Sluban M, Umek P, Jagličić Z, et al. Controlling Disorder and Superconductivity in Titanium Oxynitride Nanoribbons with Anion Exchange. ACS Nano. 2015;9(10):10133-41doi: 10.1021/acsnano.5b03742.
Sluban, M., Umek, P., Jagličić, Z., Buh, J., Šmitek, P., Mrzel, A., Bittencourt, C., Guttmann, P., Delville, M. H., Mihailović, D., & Arčon, D. (2015). Controlling Disorder and Superconductivity in Titanium Oxynitride Nanoribbons with Anion Exchange. ACS nano, 9(10), 10133-41. https://doi.org/10.1021/acsnano.5b03742
Sluban, Melita, et al. "Controlling Disorder and Superconductivity in Titanium Oxynitride Nanoribbons with Anion Exchange." ACS nano vol. 9,10 (2015): 10133-41. doi: https://doi.org/10.1021/acsnano.5b03742
Sluban M, Umek P, Jagličić Z, Buh J, Šmitek P, Mrzel A, Bittencourt C, Guttmann P, Delville MH, Mihailović D, Arčon D. Controlling Disorder and Superconductivity in Titanium Oxynitride Nanoribbons with Anion Exchange. ACS Nano. 2015 Oct 27;9(10):10133-41. doi: 10.1021/acsnano.5b03742. Epub 2015 Sep 14. PMID: 26340376.
Copy Download .nbib Format: NLM
Commentary: A BK (Slo1) channel journey from molecule to physiology.

Frontiers in pharmacology

Tricarico D, Mele A.
PMID: 28424624
Front Pharmacol. 2017 Apr 05;8:188. doi: 10.3389/fphar.2017.00188. eCollection 2017.

No abstract available.

Cite
Tricarico D, Mele A. Commentary: A BK (Slo1) channel journey from molecule to physiology. Front Pharmacol. 2017;8:188doi: 10.3389/fphar.2017.00188.
Tricarico, D., & Mele, A. (2017). Commentary: A BK (Slo1) channel journey from molecule to physiology. Frontiers in pharmacology, 8188. https://doi.org/10.3389/fphar.2017.00188
Tricarico, Domenico, and Mele, Antonietta. "Commentary: A BK (Slo1) channel journey from molecule to physiology." Frontiers in pharmacology vol. 8 (2017): 188. doi: https://doi.org/10.3389/fphar.2017.00188
Tricarico D, Mele A. Commentary: A BK (Slo1) channel journey from molecule to physiology. Front Pharmacol. 2017 Apr 05;8:188. doi: 10.3389/fphar.2017.00188. eCollection 2017. PMID: 28424624; PMCID: PMC5380717.
Copy Download .nbib Format: NLM
Therapeutic Approaches to Genetic Ion Channelopathies and Perspectives in Drug Discovery.

Frontiers in pharmacology

Imbrici P, Liantonio A, Camerino GM, De Bellis M, Camerino C, Mele A, Giustino A, Pierno S, De Luca A, Tricarico D, Desaphy JF, Conte D.
PMID: 27242528
Front Pharmacol. 2016 May 10;7:121. doi: 10.3389/fphar.2016.00121. eCollection 2016.

In the human genome more than 400 genes encode ion channels, which are transmembrane proteins mediating ion fluxes across membranes. Being expressed in all cell types, they are involved in almost all physiological processes, including sense perception, neurotransmission, muscle...

Cite
Imbrici P, Liantonio A, Camerino GM, et al. Therapeutic Approaches to Genetic Ion Channelopathies and Perspectives in Drug Discovery. Front Pharmacol. 2016;7:121doi: 10.3389/fphar.2016.00121.
Imbrici, P., Liantonio, A., Camerino, G. M., De Bellis, M., Camerino, C., Mele, A., Giustino, A., Pierno, S., De Luca, A., Tricarico, D., Desaphy, J. F., & Conte, D. (2016). Therapeutic Approaches to Genetic Ion Channelopathies and Perspectives in Drug Discovery. Frontiers in pharmacology, 7121. https://doi.org/10.3389/fphar.2016.00121
Imbrici, Paola, et al. "Therapeutic Approaches to Genetic Ion Channelopathies and Perspectives in Drug Discovery." Frontiers in pharmacology vol. 7 (2016): 121. doi: https://doi.org/10.3389/fphar.2016.00121
Imbrici P, Liantonio A, Camerino GM, De Bellis M, Camerino C, Mele A, Giustino A, Pierno S, De Luca A, Tricarico D, Desaphy JF, Conte D. Therapeutic Approaches to Genetic Ion Channelopathies and Perspectives in Drug Discovery. Front Pharmacol. 2016 May 10;7:121. doi: 10.3389/fphar.2016.00121. eCollection 2016. PMID: 27242528; PMCID: PMC4861771.
Copy Download .nbib Format: NLM
Arabidopsis D6PK is a lipid domain-dependent mediator of root epidermal planar polarity.

Nature plants

Stanislas T, Hüser A, Barbosa IC, Kiefer CS, Brackmann K, Pietra S, Gustavsson A, Zourelidou M, Schwechheimer C, Grebe M.
PMID: 27251533
Nat Plants. 2015 Nov 02;1:15162. doi: 10.1038/nplants.2015.162.

Development of diverse multicellular organisms relies on coordination of single-cell polarities within the plane of the tissue layer (planar polarity). Cell polarity often involves plasma membrane heterogeneity generated by accumulation of specific lipids and proteins into membrane subdomains. Coordinated...

Cite
Stanislas T, Hüser A, Barbosa IC, et al. Arabidopsis D6PK is a lipid domain-dependent mediator of root epidermal planar polarity. Nat Plants. 2015;1:15162doi: 10.1038/nplants.2015.162.
Stanislas, T., Hüser, A., Barbosa, I. C., Kiefer, C. S., Brackmann, K., Pietra, S., Gustavsson, A., Zourelidou, M., Schwechheimer, C., & Grebe, M. (2015). Arabidopsis D6PK is a lipid domain-dependent mediator of root epidermal planar polarity. Nature plants, 115162. https://doi.org/10.1038/nplants.2015.162
Stanislas, Thomas, et al. "Arabidopsis D6PK is a lipid domain-dependent mediator of root epidermal planar polarity." Nature plants vol. 1 (2015): 15162. doi: https://doi.org/10.1038/nplants.2015.162
Stanislas T, Hüser A, Barbosa IC, Kiefer CS, Brackmann K, Pietra S, Gustavsson A, Zourelidou M, Schwechheimer C, Grebe M. Arabidopsis D6PK is a lipid domain-dependent mediator of root epidermal planar polarity. Nat Plants. 2015 Nov 02;1:15162. doi: 10.1038/nplants.2015.162. PMID: 27251533.
Copy Download .nbib Format: NLM
The Clinical Significance of IDH Mutations in Essential Thrombocythemia and Primary Myelofibrosis.

Journal of clinical medicine research

Yonal-Hindilerden I, Daglar-Aday A, Hindilerden F, Akadam-Teker B, Yilmaz C, Nalcaci M, Yavuz AS, Sargin D.
PMID: 26668680
J Clin Med Res. 2016 Jan;8(1):29-39. doi: 10.14740/jocmr2405w. Epub 2015 Dec 03.

BACKGROUND: Limited data exist regarding impact of IDH mutations in Philadelphia-negative myeloproliferative neoplasms (Ph-negative MPNs). Prognostic significance of IDH mutations was asessed in 184 Ph-negative MPN patients - 107 essential thrombocythemia (ET) and 77 primary myelofibrosis (PMF).METHODS: High-resolution melting...

Cite
Yonal-Hindilerden I, Daglar-Aday A, Hindilerden F, et al. The Clinical Significance of IDH Mutations in Essential Thrombocythemia and Primary Myelofibrosis. J Clin Med Res. 2015;8(1):29-39doi: 10.14740/jocmr2405w.
Yonal-Hindilerden, I., Daglar-Aday, A., Hindilerden, F., Akadam-Teker, B., Yilmaz, C., Nalcaci, M., Yavuz, A. S., & Sargin, D. (2016). The Clinical Significance of IDH Mutations in Essential Thrombocythemia and Primary Myelofibrosis. Journal of clinical medicine research, 8(1), 29-39. https://doi.org/10.14740/jocmr2405w
Yonal-Hindilerden, Ipek, et al. "The Clinical Significance of IDH Mutations in Essential Thrombocythemia and Primary Myelofibrosis." Journal of clinical medicine research vol. 8,1 (2016): 29-39. doi: https://doi.org/10.14740/jocmr2405w
Yonal-Hindilerden I, Daglar-Aday A, Hindilerden F, Akadam-Teker B, Yilmaz C, Nalcaci M, Yavuz AS, Sargin D. The Clinical Significance of IDH Mutations in Essential Thrombocythemia and Primary Myelofibrosis. J Clin Med Res. 2016 Jan;8(1):29-39. doi: 10.14740/jocmr2405w. Epub 2015 Dec 03. PMID: 26668680; PMCID: PMC4676343.
Copy Download .nbib Format: NLM
PSYCHIATRIC DISORDERS ASSOCIATED WITH FXTAS.

Current psychiatry reviews

Seritan AL, Ortigas M, Seritan S, Bourgeois JA, Hagerman RJ.
PMID: 25620899
Curr Psychiatry Rev. 2013;9(1):59-64. doi: 10.2174/157340013805289699.

Carriers of the FMR1 premutation (with 55-200 CGG repeats) may present with multiple medical and psychiatric disorders. Middle-aged carriers (males more often than females) may suffer from fragile X-associated tremor/ataxia syndrome (FXTAS). FXTAS is a newly discovered neurodegenerative disease...

Cite
Seritan AL, Ortigas M, Seritan S, et al. PSYCHIATRIC DISORDERS ASSOCIATED WITH FXTAS. Curr Psychiatry Rev. 2013;9(1):59-64doi: 10.2174/157340013805289699.
Seritan, A. L., Ortigas, M., Seritan, S., Bourgeois, J. A., & Hagerman, R. J. (2013). PSYCHIATRIC DISORDERS ASSOCIATED WITH FXTAS. Current psychiatry reviews, 9(1), 59-64. https://doi.org/10.2174/157340013805289699
Seritan, Andreea L, et al. "PSYCHIATRIC DISORDERS ASSOCIATED WITH FXTAS." Current psychiatry reviews vol. 9,1 (2013): 59-64. doi: https://doi.org/10.2174/157340013805289699
Seritan AL, Ortigas M, Seritan S, Bourgeois JA, Hagerman RJ. PSYCHIATRIC DISORDERS ASSOCIATED WITH FXTAS. Curr Psychiatry Rev. 2013;9(1):59-64. doi: 10.2174/157340013805289699. PMID: 25620899; PMCID: PMC4304643.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 1490 entries